idarubicin has been researched along with Hypermelanosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boulinguez, S; Gadaud, N; Gladieff, L; Guenounou, S; Lamant, L; Masson Regnault, M; Recher, C; Roche, H; Sibaud, V; Tournier, E | 1 |
| Borecky, DJ; Keeling, JH; Stephenson, JJ; Vukelja, SJ | 1 |
1 review(s) available for idarubicin and Hypermelanosis
| Article | Year |
|---|---|
Chemotherapy-Related Reticulate Hyperpigmentation: A Case Series and Review of the Literature.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Eruptions; Female; Humans; Hyperpigmentation; Idarubicin; Lomustine; Male; Middle Aged; Paclitaxel; Vincristine | 2015 |
1 other study(ies) available for idarubicin and Hypermelanosis
| Article | Year |
|---|---|
Idarubicin-induced pigmentary changes of the nails.
Topics: Adult; Antibiotics, Antineoplastic; Biopsy; Humans; Hyperpigmentation; Idarubicin; Leukemia, Myeloid, Acute; Male; Nail Diseases | 1997 |